• SE Asia (HQ)

    +65 3158 9910

  • Australia

    1300 798 820

  • New Zealand

    +64 9801 0299

Resources

Australia

Approved Product Information
Consumer Medicine Information

Brunei

Approved ---

Malaysia

Approved Product Information
Consumer Medicine Information

New Zealand

Approved Data Sheet
Consumer Medicine Information

Philippines

Application Under Evaluation ---

Singapore

Approved Product Information

Thailand

Application to be Submitted ---

Vietnam

Application to be Submitted ---

General

  Healthcare Professional Information

Resources

Australia

Approved Product Information
Consumer Medicine Information

Malaysia

Application to be Submitted ---

Singapore

Application to be Submitted ---

New Zealand

Application Under Evaluation ---

General

  Access Program

Resources

Australia

Approved Product Information
Consumer Medicine Information

Brunei

Approved ---

Malaysia

Approved Product Information

Singapore

Approved Product Information

New Zealand

Application Submitted ---

Thailand

Application to be Submitted ---

Vietnam

Application to be Submitted ---

General

  Healthcare Professional Information
Access Program

Resources

Australia

Approved Product Information
Consumer Medicine Information

Singapore

Approved Product Information

General

  Access Program

Resources

Australia

Approved Product Information
Consumer Medicine Information

New Zealand

Application Under Evaluation ---
The Oncotype DX® Breast Cancer Assay provides patients and their physicians with individualised information about their breast cancer to guide decisions on how to proceed with treatment. More info
The Oncotype DX® Prostate Cancer Assay provides men with newly diagnosed, low-risk prostate cancer and their urologists, critical information to help guide decisions about treatment. More info

Meeting the unmet needs
of patients in Australia,
New Zealand and
Southeast Asia